release or is otherwise written in a promotional tone . please help by either rewriting this article from a neutral point of view or by moving this article to wikinews . when appropriate blatant advertising may be marked for speedy deletion with db spam . june 2015 mannkind corporation type public company traded as nasdaq mnkd industry biotechnology founded 1991 headquarters valencia ca united states website www.mannkindcorp.com mannkind corporation based in valencia california is a biopharmaceutical company focusing on the discovery development and commercialization of therapeutic products for diseases such as diabetes and cancer . the company while founded in february 1991 took its present form in 2003 as a merger of three companies owned by alfred e. mann named after its founder who has invested approximately 900 million in the firm . one of the former companies pharmaceutical discovery was purchased in 2001 from solomon steiner ; with that purchase mannkind acquired the technosphere molecule and medtone inhaler upon which was developed its lead product afrezza inhalable insulin . 1 contents 1 leadership 2 facilities 3 products and product candidates 4 lawsuits 5 references 6 external links leadership edit mann was chief executive officer until january 12 2015 when hakan edstrom became ceo and mann transitioned to executive chairman . 2 in november 2015 hakan edstrom stepped down as ceo and president and will remain until july 2017 to provide other services for the company . company founder alfred mann stepped in as interim ceo . 3 8 k file on november 19 2015 . in january 2016 mannkind corporation announced that duane m. desisto would become president and chief executive officer effective january 5 2016 . facilities edit mannkind s corporate headquarters are in valencia california . the afrezza manufacturing facility is in danbury connecticut . 4 products and product candidates edit afrezza is an ultra rapid acting insulin peaking 12 to 15 minutes following inhalation . the fda approved afrezza on june 27 2014 with a 13 1 vote for type 1 diabetes and 14 0 vote for type 2 diabetes . 5 on august 11 2014 mannkind entered into an exclusive global licensing agreement with sanofi for afrezza sales . 6 under the agreement mannkind received 150 million cash from sanofi in exchange for sharing profits and losses of sales of afrezza with 65 % for sanofi and 35 % for mannkind . on january 5 2016 mannkind corporation announced the termination of the license and collaboration agreement with sanofi . 6 7 the firm s oncology drug candidates mkc1106 pp for prostate and mkc1106 mt for advanced stage melanoma in phase ii study use the body s immune system immunotherapy to target specific melanoma antigen prame and prostate specific membrane antigen psma . 8 the firm has stated that it is developing a next generation inhalation technology a miniature breath powered inhaler used in combination with single use cartridges containing pre metered doses . initial pharmacokinetic studies were followed by studies of safety and efficiency involving technosphere formulations of different therapeutic proteins . 9 10 lawsuits edit in january 2011 a lawsuit was filed against mannkind corporation alleging that mannkind s stock price was artificially inflated as a result of untrue or materially misleading statements related to mannkind s communications with the fda about its new product afrezza resulting in the mannkind co. stock being deemed toxic . 11 a settlement of 16 million was reached in 2012 . 12 it should be noted that company stock performance during this period was strongly influenced by martin shrkeli who shorted the company stock while contacting the fda with concerns that would cost the company two years in delays and hundreds of millions of dollars link to washington post references edit mannkind corporation 8k filing with securities and exchange commission 2009 www.sec.gov march 16 2009 calia michael january 12 2015 . mannkind appoints edstrom ceo as mann steps aside . wall street journal . retrieved january 13 2015 . mannkind ceo steps down . newstimes.com . 23 november 2015 . mannkind regains marketing rights to inhaled insulin westfair communications . westfaironline.com . retrieved 2016 04 26 . mannkind corporation announces fda approval of afrezza ; a novel rapid acting inhaled insulin for the treatment of diabetes . mannkind corporation . retrieved december 25 2014 . a b sanofi and mannkind announce global licensing agreement for afrezza insulin human rapid acting inhaled insulin . mannkind corporation . retrieved december 25 2014 . http investors.mannkindcorp.com releasedetail.cfm releaseid 948810 stockmatusow 2012 01 31 . the curious case of mannkind corporation . seeking alpha . retrieved 2016 04 26 . mannkind corporation 8k filing with securities and exchange commission 2009 brashier dick b. s. ; khadka anjan ; anantharamu tejus ; sharma ashok kumar ; gupta a. k. ; sharma sushil ; dahiya n. 2015 01 01 . inhaled insulin a puff than a shot before meals . journal of pharmacology & pharmacotherapeutics . 6 3 126 129 . doi 10.4103 0976 500x .162013 . issn 0976 500x . pmc 4544132 . pmid 26311994 . lawsuit against mannking corp. . mannkind corporation investor files lawsuit over alleged securities laws violations . external links edit www.mannkindcorp.com retrieved from https en.wikipedia.org w index.php title mannkind corporation & oldid 735797712 categories biotechnology companies of the united statescompanies in the nasdaq biotechnology indexcompanies listed on nasdaqsanta clarita californiahidden categories articles with a promotional tone from june 2015all articles with a promotional tone navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages add links this page was last modified on 23 august 2016 at 04 53 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view